Periodic Validation of High Antidiabetic Potentials of Unripe Plantain in Comparison with Glibenclamide and Fansidar
E. O. Jimmy and M. A. Okon
DOI : 10.3844/ajptsp.2012.15.18
American Journal of Pharmacology and Toxicology
Volume 7, Issue 1
Problem statement: The antidiabetic potentials of aqueous extract of musa paradisciaca (unripe plantain fruit) were investigated in alloxan induced diabetic rats. The extract at a dosage of 120 mg kg-1 produced a significant (p<0.001) reduction in glucose level by 85% on day 7, 78% on day 14, 64% on day 21 and 44% on day 28. Approach: The extract at the dosage of 80 mg kg-1 produced a significant (p<0.01) reduction in glucose concentration by 86% on day 7, 79% on day 14 64%, day 21 and 458% on day 28. With 40 mg kg-1 glucose level was 83% on day 7, 75% on day 14, 68%, day 21 and 58, 64% on day 21 and 58% on day 28. Results: Fansidar at the calculated average animal dosage 9-22.5 mg kg-1 from that of man produced a significant (p<0.01) reduction in glucose concentration by 81% on day 7 71% on day 14, 58% on day 21 and on day 28 a shooting to 111%. Comparing the fasting blood glucose levels of extract and fansidar with known antidiabetic drug; Gliben clamide of 6.75 mg kg-1 had the following on day 7; it was 96, 86% on day 14, 45% on day 21 and 81% on day 28. Conclusion: It is concluded that extract of unripe plantain fruit showed high antidiabetic properties than glibenclamide a known potent antidiabetic drug and fansidar is also demonstrated a good degree of antidabetic potentials.
© 2012 E. O. Jimmy and M. A. Okon. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.